Aptus Pharma Ltd
₹0.00▲ +0.00 (+0.00%)
544529·NSE·Consumer Goods
Market Cap
428.77 Cr
PE Ratio
—
Volume
—
Day High - Low
—
52W High-Low
259.95 - 32.32
₹0.00▲ +0.00 (+0.00%)
Market Cap428.77 Cr
PE Ratio—
Volume—
Day High - Low—
52W High-Low259.95 - 32.32
Aptus Pharma Ltd (544529): company summary
Aptus Pharma Ltd (544529) is a micro-cap Consumer Goods company valued at ₹429 crore operating in Household Appliances on the NSE and BSE.
Aptus Pharma Ltd (544529) is a micro-cap Consumer Goods company valued at ₹429 crore operating in Household Appliances on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 49.6% a year over three years; profit grew 189.3% a year, ahead of revenue — margins are expanding. Return on equity is 30.5%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here; the stock trades at 21.59 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
5.2/10
Weak
Fair Value
Sign in to see
ROE
30.50%
Strong
P/E
—
Debt / Equity
0.31
Moderate
Industry
Consumer Goods
Household Appliances
Overall View
Mixed
Price performance
52W₹32.32
₹259.95
DocStoX take
Supported by growth (8.8) and quality (7.0), but held back by valuation (0.0). Growth looks strong at 8.8, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence5.2
/10
Weak
Quality
Solid
ROE 30.5%
Valuation
Expensive
P/B 21.6× vs 2.5× warranted by ROE
Growth
Strong
Revenue +49.6% 3Y CAGR
Risk
Elevated
D/E 0.31
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹429 Cr
52W High / Low
₹260 / ₹32
Dividend Yield
0.00%
Promoter Holding
72.89%
EPS (TTM)
₹2.48
Book Value
₹11.65
Key highlights
- Profit compounding 189% a year
- Revenue compounding 50% a year
- Capital works hard — ROCE 38%
- Valuation is weak (0.0/10)
- Small ₹429 cr company — thinner liquidity
4 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Consumer Goods stocks · Household Appliances
Explore Aptus Pharma Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Aptus Pharma Ltd peers in Consumer Goods
Other Consumer Goods stocks on the NSE & BSE. See the full Consumer Goods sector list.
Related tools & concepts
Value Aptus Pharma Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing